David Petrie Durham, PhD

Associate Research Scientist in Epidemiology (Microbial Diseases)

Public Health Interests

Cost-effectiveness; Disease transmission; Modeling

Research Organizations

School of Public Health: Epidemiology of Microbial Diseases

Extensive Research Description

Hepatitis C elimination

Zika and dengue dynamics and vaccination policy

HIV intervention effectiveness

Selected Publications

  • California Universal Health Care: An economic stimulus and life-saving proposal AP Galvani, DP Durham, SH Vermund, MC Fitzpatrick. California Universal Health Care: An economic stimulus and life-saving proposal. The Lancet, 2017; in press.
  • Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. AR Brock, JV Ross, S Greenhalgh, DP Durham, AP Galvani, S Parikh, A Esterman. Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Infectious Disease Modelling, 2017; in press.
  • Evaluating the effectiveness of localized control strategies to curtail chikungunya.

    ML Ndeffo Mbah*, DP Durham*, LA Skrip, EO Nsoesie, JS Brownstein, D Fish, AP Galvani. Evaluating the effectiveness of localized control strategies to curtail chikungunya. Scientific Reports, 2016; 6:23997. *Joint first authorship

  • The national and state level impact and cost-effectiveness of nonavalent HPV vaccination in the US.

    DP Durham, ML Ndeffo Mbah, L Skrip, FK Jones, CT Bauch, AP Galvani. The national and state level impact and cost-effectiveness of nonavalent HPV vaccination in the US. Proceedings of the National Academy of Science, 2016; 113(18):5107-12.

  • Quantifying transmission of Clostridium difficile in and out of health care settings.

    DP Durham, MA Olsen, ER Dubberke, AP Galvani, and JP Townsend. Quantifying transmission of Clostridium difficile in and out of health care settings. Emerging Infectious Diseases 2016; 22(4):608-616.

  • The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

    DP Durham, LA Skrip, RD Bruce, S Vilarinho, EH Elbasha, AP Galvani, JP Townsend. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Clin Infect Dis, 2016; 62(3):298-304

  • Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.

    D Gurarie, N Yoon, E Li, M Ndeffo-Mbah, DP Durham, AE Phillips, HO Aurelio, J Ferro, AP Galvani, CH King. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasit Vectors, 2015; 8: 529.

  • Spatial and Temporal Clustering of Chikungunya Virus Transmission in Dominica.

    EO Nsoesie, RP Ricketts, HE Brown, D Fish, DP Durham, ML Ndeffo Mbah, T Christian, S Ahmed, C Marcellin, E Shelly, K Owers, N Wenzel, AP Galvani, JS Brownstein. Spatial and Temporal Clustering of Chikungunya Virus Transmission in Dominica. PLoS Negl Trop Dis, 2015 Aug; 9(8): e0003977.

  • Country- and age-specific optimal allocation of dengue vaccines.

    M Ndeffo-Mbah, DP Durham, J Medlock, A Galvani. Country- and age-specific optimal allocation of dengue vaccines. J Theor Biol, 2014; 342:15-22.

  • Dengue dynamics and vaccine cost-effectiveness in Brazil.

    DP Durham, ML Ndeffo Mbah, J Medlock, PM Luz, LA Meyers, AD Paltiel, AP Galvani. Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine, 2013; 31(37):3957-61.

  • Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.

    DP Durham, E Poolman, Y Ibuka, J Townsend, A Galvani. Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis, 2012; 206(8):1291-8.

  • The interactive roles of Aedes aegypti super-production and human density in dengue transmission.

    H Padmanabha, DP Durham, F Correa, M Diuk-Wasser, A Galvani. The interactive roles of Aedes aegypti super-production and human density in dengue transmission. PLoS Negl Trop Dis, 2012;6(8):e1799.

  • Incorporating Individual Health Protective Decisions into Disease Transmission Models: A Mathematical Framework. DP Durham, E Casman. Incorporating Individual Health Protective Decisions into Disease Transmission Models: A Mathematical Framework. Journal of the Royal Society Interface, 2012; 9(68):562-570.
  • Deriving Behavior Model Parameters from Survey Data: Self-Protective Behavior Adoption During the 2009–2010 Influenza A(H1N1) Pandemic. DP Durham, E Casman, S Albert. Deriving Behavior Model Parameters from Survey Data: Self-Protective Behavior Adoption During the 2009–2010 Influenza A(H1N1) Pandemic. Risk Analysis, 2012; 32(12):2020-2031.
  • Threshold Conditions for the Persistence of Plague Transmission in Urban Rats. DP Durham, E Casman. Threshold Conditions for the Persistence of Plague Transmission in Urban Rats. Risk Analysis, 2009; 29(12):1655-1663.

Edit this profile

Contact Info

David Petrie Durham, PhD
Office Location
135 College Street, Ste Suite 200
New Haven, CT 06510
View on map...
Mailing Address
135 College St, Ste 200
Room 218

New Haven, Connecticut 06511